Regenxbio Debt Ratio from 2010 to 2024

RGNX Stock

USD 9.58 0.01 0.10%

Regenxbio Debt Ratio yearly trend continues to be fairly stable with very little volatility. Debt Ratio will likely drop to 0.01 in 2024. During the period from 2010 to 2024, Regenxbio Debt Ratio regression line of annual values had r-squared of 0.24 and arithmetic mean of 0.15. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.01231423

Current Value

0.0117

Quarterly Volatility

0.28675638

Credit Downgrade

Yuan Drop

Covid

Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.

Check out the analysis of Regenxbio Correlation against competitors.

For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Regenxbio over the last few years. It is Regenxbio's Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

Regenxbio Debt Ratio Regression Statistics

	Arithmetic Mean	0.15
	Geometric Mean	0.02
	Coefficient Of Variation	195.48
	Mean Deviation	0.19
	Median	0.01
	Standard Deviation	0.29
	Sample Variance	0.08
	Range	1.0944
	R-Value	(0.49)
	Mean Square Error	0.07
	R-Squared	0.24
	Significance	0.06
	Slope	(0.03)
	Total Sum of Squares	1.15

Regenxbio Debt Ratio History

	2024	0.0117
	2023	0.0123
	2022	0.007197
	2021	0.001573
	2020	0.00353
	2015	0.004862
	2014	1.1

Other Fundumenentals of Regenxbio

Cash Flow To Debt Ratio

Regenxbio Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Short Term Investments	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Property Plant Equipment	Capital Surpluse	Net Invested Capital	Net Working Capital	Long Term Debt Total	Capital Stock
Total Assets		0.96	0.75	-0.58	-0.54	0.71	0.84	0.89	0.96	0.53	-0.63	0.95	0.68	0.69	0.83	-0.17	0.73	0.89	0.92	0.85	-0.17	-0.17
Total Stockholder Equity	0.96		0.82	-0.55	-0.43	0.6	0.76	0.73	0.93	0.42	-0.67	0.96	0.69	0.7	0.87	-0.13	0.64	0.81	0.94	0.82	-0.13	-0.13
Current Deferred Revenue	0.75	0.82		-0.5	-0.17	0.34	0.69	0.5	0.7	0.14	-0.59	0.74	0.5	0.6	0.79	0.13	0.38	0.6	0.76	0.59	0.13	0.13
Net Debt	-0.58	-0.55	-0.5		-0.2	0.07	-0.53	-0.51	-0.61	0.26	0.29	-0.42	0.02	-0.3	-0.59	-0.4	0.02	-0.27	-0.49	-0.68	-0.4	-0.4
Retained Earnings	-0.54	-0.43	-0.17	-0.2		-0.93	-0.55	-0.63	-0.56	-0.97	0.48	-0.6	-0.66	-0.56	-0.09	0.8	-0.89	-0.73	-0.4	-0.41	0.8	0.8
Accounts Payable	0.71	0.6	0.34	0.07	-0.93		0.64	0.77	0.68	0.95	-0.49	0.7	0.74	0.56	0.34	-0.64	0.94	0.84	0.6	0.53	-0.64	-0.64
Net Receivables	0.84	0.76	0.69	-0.53	-0.55	0.64		0.83	0.9	0.49	-0.5	0.78	0.65	0.59	0.51	-0.18	0.6	0.81	0.73	0.86	-0.18	-0.18
Total Liab	0.89	0.73	0.5	-0.51	-0.63	0.77	0.83		0.86	0.62	-0.44	0.77	0.53	0.55	0.61	-0.21	0.77	0.88	0.72	0.75	-0.21	-0.21
Total Current Assets	0.96	0.93	0.7	-0.61	-0.56	0.68	0.9	0.86		0.52	-0.67	0.92	0.72	0.74	0.69	-0.18	0.66	0.86	0.85	0.91	-0.18	-0.18
Short Term Debt	0.53	0.42	0.14	0.26	-0.97	0.95	0.49	0.62	0.52		-0.48	0.57	0.65	0.46	0.14	-0.79	0.91	0.71	0.42	0.37	-0.79	-0.79
Common Stock	-0.63	-0.67	-0.59	0.29	0.48	-0.49	-0.5	-0.44	-0.67	-0.48		-0.69	-0.54	-0.69	-0.45	0.22	-0.44	-0.53	-0.49	-0.49	0.22	0.22
Net Tangible Assets	0.95	0.96	0.74	-0.42	-0.6	0.7	0.78	0.77	0.92	0.57	-0.69		0.76	0.74	0.78	-0.27	0.75	0.91	0.88	0.75	-0.27	-0.27
Short Term Investments	0.68	0.69	0.5	0.02	-0.66	0.74	0.65	0.53	0.72	0.65	-0.54	0.76		0.68	0.36	-0.3	0.63	0.8	0.62	0.55	-0.3	-0.3
Deferred Long Term Liab	0.69	0.7	0.6	-0.3	-0.56	0.56	0.59	0.55	0.74	0.46	-0.69	0.74	0.68		0.43	-0.18	0.51	0.68	0.55	0.55	-0.18	-0.18
Long Term Investments	0.83	0.87	0.79	-0.59	-0.09	0.34	0.51	0.61	0.69	0.14	-0.45	0.78	0.36	0.43		0.14	0.46	0.61	0.85	0.58	0.14	0.14
Short Long Term Debt	-0.17	-0.13	0.13	-0.4	0.8	-0.64	-0.18	-0.21	-0.18	-0.79	0.22	-0.27	-0.3	-0.18	0.14		-0.69	-0.32	-0.22	-0.2	1.0	1.0
Property Plant Equipment	0.73	0.64	0.38	0.02	-0.89	0.94	0.6	0.77	0.66	0.91	-0.44	0.75	0.63	0.51	0.46	-0.69		0.85	0.68	0.52	-0.69	-0.69
Capital Surpluse	0.89	0.81	0.6	-0.27	-0.73	0.84	0.81	0.88	0.86	0.71	-0.53	0.91	0.8	0.68	0.61	-0.32	0.85		0.77	0.67	-0.32	-0.32
Net Invested Capital	0.92	0.94	0.76	-0.49	-0.4	0.6	0.73	0.72	0.85	0.42	-0.49	0.88	0.62	0.55	0.85	-0.22	0.68	0.77		0.84	-0.22	-0.22
Net Working Capital	0.85	0.82	0.59	-0.68	-0.41	0.53	0.86	0.75	0.91	0.37	-0.49	0.75	0.55	0.55	0.58	-0.2	0.52	0.67	0.84		-0.2	-0.2
Long Term Debt Total	-0.17	-0.13	0.13	-0.4	0.8	-0.64	-0.18	-0.21	-0.18	-0.79	0.22	-0.27	-0.3	-0.18	0.14	1.0	-0.69	-0.32	-0.22	-0.2		1.0
Capital Stock	-0.17	-0.13	0.13	-0.4	0.8	-0.64	-0.18	-0.21	-0.18	-0.79	0.22	-0.27	-0.3	-0.18	0.14	1.0	-0.69	-0.32	-0.22	-0.2	1.0

Click cells to compare fundamentals

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Debt Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Debt Ratio	0.01	0.01
Cash Flow To Debt Ratio	(30.90)	(29.36)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Regenxbio Debt Ratio from 2010 to 2024

Latest Regenxbio's Debt Ratio Growth Pattern

Regenxbio Debt Ratio Regression Statistics

Regenxbio Debt Ratio History

Other Fundumenentals of Regenxbio

Regenxbio Debt Ratio component correlations

About Regenxbio Financial Statements

Also Currently Popular

Additional Tools for Regenxbio Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY